BridgeBio Pharma Inc. (BBIO): Billionaire Tom Steyer Admires Upside Potential of This Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is simply a comparatively caller summation to the 13F portfolio of Farallon Capital. The money archetypal disclosed a involvement successful the steadfast successful the 3rd 4th of 2024. This presumption comprised 1.7 cardinal shares. In the months since then, the hedge money has aggressively built up this holding. Filings for the 4th fourth of 2025 amusement that the money owned 9 cardinal shares successful the firm, up adjacent to 10% compared to filings for the erstwhile quarter. The steadfast operates arsenic a biopharmaceutical institution that discovers, develops, and delivers medicines for patients with familial diseases.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) has travel successful absorption of elite investors since the commercialized motorboat of Attruby for ATTR-CM, transthyretin amyloid cardiomyopathy. In the Q4 2025 net report, the institution revealed a 35% quarter-over-quarter maturation successful nett merchandise revenue. Long-term information released successful March showed a staggering 44.7% simplification successful all-cause mortality done period 54. Hedge funds presumption this near-complete stabilization of the TTR macromolecule arsenic a important competitory vantage implicit Pfizer’s bequest drug, Vyndamax. In January, BridgeBio successfully issued $632.5 cardinal successful convertible notes. This superior injection, combined with rising Attruby sales, gives the institution a beardown equilibrium expanse to money 3 simultaneous launches. Hedge funds prioritize companies that tin standard without needing to perpetually instrumentality to the equity markets for dilutive raises.

While we admit the imaginable of BBIO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best Defensive Stocks to Invest In Now and 14 Best Low Risk High Growth Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey connected Google News.